Lipohypertrophies (lipos) are among the factors that might adversely affect blood sugar levels in diabetes management. They are a typical adverse effect for individuals receiving insulin therapy. Up to 50% of people afflicted experience lipos, which is a localized increase in benign subcutaneous fatty tissue growth, near the injection sites. The lipos appear as fat pillows, mounds, lumps, or folds.
The tissue seems tighter than usual when touched. You might feel knots or hard areas. Technical diagnostic techniques have also recently been accessible, such as ultrasound or high-quality thermal imaging cameras (thermography).